Calithera Biosciences Net Tangible Assets

Calithera Biosciences (CALA) currently reports a net tangible assets of $20M as of December 2022. That compares with $-490M in the prior-year period — up 104.2% year over year. Use the charts on this page to explore Calithera Biosciences's net tangible assets history and peer comparisons.

Calithera Biosciences's net tangible assets increased from $-490M to $20M — a 104.2% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Calithera Biosciences reported $20M in net tangible assets as of December 2022. That compares with $-490M in the prior-year period — up 104.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $20M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Calithera Biosciences, and consider following CALA for alerts when major investors trade the stock.

Calithera Biosciences is classified in the Healthcare sector. On net tangible assets, it currently shows $20M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CALA with unrelated industries.